Loading...
Trastuzumab Targeted Neratinib Loaded Poly-Amidoamine Dendrimer Nanocapsules for Breast Cancer Therapy
BACKGROUND: Human epidermal growth factor receptor2 (Her2) positive breast cancer represents 25% of breast cancer cases. Targeted therapy with Her2 monoclonal antibody, trastuzumab (TZ), represents the first-line treatment for this type of breast cancer. In addition, neratinib, an irreversible inhib...
Na minha lista:
| Udgivet i: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398757/ https://ncbi.nlm.nih.gov/pubmed/32801698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S256898 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|